Published September 2018 | Version v1
Journal article

Recent Advances in Copper Intercalators as Anticancer Agents

  • 1. RGUKT, Department of Chemistry (India)
  • 2. CSIR−Indian Institute of Chemical Technology, Inorganic & Physical Chemistry Division (India)
  • 3. Eritrea Institute of Technology, Department of Chemical Engineering (Eritrea)

Description

Copper is a part of various enzymes and helps them to function properly. It can be effectively used to produce promising anticancer drugs and presently, many studies are being pursued worldwide on the development of copper-based complexes as potential anticancer drugs. Herein, we briefly discuss the importance of reactive oxygen species in biological applications and copper(II) complexes as anticancer drugs. The anti-angiogenic properties of mono-nuclear copper(II) complexes have been demonstrated by in vivo chick embryo angiogenesis analysis. The plausible mechanism behind anticancer activity of these complexes is by the formation of excessive intracellular Reactive Oxygen Species (ROS). ROS is a composite term used for oxygen derivative non-radicals and free radicals of highly reactive components, that enhances the killing response of immune cells to microbial invasion. Previous reports have shown that ROS plays an important role as a messenger in cell cycling and normal cell signal transduction. .

Additional details

Identifiers

Publishing Information

Journal Title
Journal of Fluorescence (Online)
Journal Volume
28
Journal Issue
5
Journal Page Range
p. 1195-1205
ISSN
1573-4994

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50039817
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANGIOGENESIS; ANTINEOPLASTIC DRUGS; COMPLEXES; COPPER; DNA; EMBRYOS; ENZYMES; IN VIVO; NEOPLASMS; OXYGEN; RADICALS; SIGNALS
Descriptors DEC
DISEASES; DRUGS; ELEMENTS; METALS; NONMETALS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; PROTEINS; TRANSITION ELEMENTS

Optional Information

Copyright
Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature
Notes
http://www.springer-ny.com